MongoDB, Inc. (MDB) › Analysis

MongoDB, Inc. (MDB) analysis, February 25, 2026

Published February 25, 2026 · MDB chart, levels and live analysis

Key Updates

MongoDB declined -2.36% to $310.19 since the February 24th report, breaking below the psychologically significant $315 level and establishing a new 2026 low. The stock has now declined -26.09% YTD and -24.58% over the past month, accelerating its downtrend ahead of the critical Q4 FY2026 earnings release scheduled for March 2, 2026. The broader DBMS market outlook remains constructive with 5.5% CAGR growth projected through 2033, though competitive pressures intensified with MinIO's launch of AIStor Tables, which directly challenges MongoDB's positioning in the AI-powered data management space.

Current Trend

MongoDB remains in a severe downtrend with YTD performance at -26.09%, significantly underperforming the broader technology sector. The stock has breached multiple support levels, declining from $350 on February 18th to $310.19 currently, representing a -11.32% drop in just seven trading days. The 6-month performance of +42.00% has been completely eroded, with the 1-month decline of -24.58% indicating accelerating selling pressure. Key resistance now sits at $330 (previous support turned resistance), while immediate support lies at the $300 psychological level. The technical deterioration suggests institutional repositioning ahead of the March 2nd earnings announcement.

Investment Thesis

The investment thesis centers on MongoDB's positioning as a unified data platform provider serving over 60,000 customers including 75% of Fortune 100 companies, with capabilities spanning operational data, search, real-time analytics, and AI-powered data retrieval. The company operates in a DBMS market projected to grow from $80 billion in 2024 to $120 billion by 2033, driven by cloud adoption, IoT expansion, and AI-powered analytics demand. MongoDB's competitive advantage derives from its developer-first approach serving millions of developers globally and its ability to address the transition from legacy systems to cloud-based and hybrid solutions. However, the thesis faces challenges from intensifying competition, particularly from cost-competitive alternatives like MinIO's AIStor Tables, and execution concerns reflected in the severe pre-earnings stock decline.

Thesis Status

The investment thesis has deteriorated materially since the last report. While the macro DBMS market outlook remains favorable with 5.5% CAGR growth through 2033, MongoDB's stock performance suggests significant concerns about the company's ability to capture this growth profitably. The -26.09% YTD decline and accelerating downward momentum indicate investor skepticism ahead of Q4 results. The emergence of competitive threats, specifically MinIO's AIStor Tables claiming 40% cost advantages versus AWS S3 Tables and direct integration of Apache Iceberg V3, challenges MongoDB's pricing power and differentiation in the AI-powered data management segment. The thesis now hinges critically on the March 2nd earnings release demonstrating sustained revenue growth, margin expansion, and competitive positioning strength that can reverse the current negative sentiment.

Key Drivers

The immediate catalyst is MongoDB's Q4 FY2026 earnings release scheduled for March 2, 2026, covering the three months ended January 31, 2026. The pre-earnings decline of -24.58% over the past month suggests either leaked negative guidance, sector rotation, or anticipation of disappointing results. The broader DBMS market presents structural tailwinds, with growth from $80 billion in 2024 to $120 billion by 2033 driven by cloud adoption, big data analytics, and AI-powered optimization. However, competitive dynamics shifted with MinIO's general availability launch of AIStor Tables, which integrates Apache Iceberg V3 Catalog REST API directly into the data store and claims up to 40% cost savings versus AWS S3 Tables, potentially pressuring MongoDB's pricing in the enterprise AI segment.

Technical Analysis

MongoDB has broken through critical support levels in a cascading fashion: $350 breached on February 20th, $330 broken on February 24th, and now $315 violated at $310.19. The stock is trading at its lowest level since the analysis period began, with the -14.57% weekly decline indicating capitulation-level selling. The 6-month gain of +42.00% has been nearly eliminated by the -24.58% monthly decline, suggesting a complete reversal of the previous uptrend. Immediate resistance sits at $330 (previous support), with major resistance at $350. Downside support lies at the psychological $300 level, with further support in the $285-$290 range if current levels fail. The relative strength has deteriorated significantly, and momentum indicators suggest oversold conditions, though falling knife dynamics typically precede earnings-driven volatility. Volume patterns would need confirmation, but the magnitude of recent declines suggests institutional distribution rather than retail panic.

Bull Case

Bear Case

Get a message when the MDB picture changes — the agent team watches the levels and the news for you.Create a free account

More MDB analyses